Publication
Patient-centricity in the Biopharmaceutical Industry: Are We Nearly There Yet?
Jul 30, 2025
Download

The concept of patient-centricity has come a long way in the past few decades. However, applications of patient-centricity in intervention development remain inconsistent. Critics have questioned the validity of patient-centric claims that are seen as performative checkbox exercises. Patients surveyed largely think that pharma has little regard for their perspectives, believing corporate priorities are instead driven by profits.

A new book compiled by the Patient Centered Solutions team at IQVIA gathers insights on patient-centric intervention development from a diverse group of more than 30 experts. These contributors include pharma company executives, biotech manufacturers, regulatory representatives, patient representatives, patient advocacy group (PAG) leaders, patient experience data (PED) researchers, and payer and health technology agency (HTA) advisors.

In formats ranging from reviews of the research and personal narratives to poetry and short fiction, the contributors share their thoughts on where patient-centricity stands today, what improvements are still to be made, and how the voice of the patient will influence the future of healthcare.

Related solutions

Contact Us